Traws Pharma, Inc. (TRAW) — SC 13D/A Filings
All SC 13D/A filings from Traws Pharma, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
OrbiMed Amends Traws Pharma Stake Filing
— Nov 6, 2024 Risk: medium
OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC, collectively holding 13.7% of Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) as of November 6,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX